← Back to AKTS

Aktis Oncology, Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026
$3.4$3.2$1.6$1.4
−$24−$18−$18−$15
−$0.44−$0.38−$22.39−$18.60
55490.80.8

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.